Semaglutide is a new, effective, FDA approved weight loss peptide that is administered subcutaneously once weekly. It is for adults with obesity or overweight who also have weight related medical problems to help them lose weight and keep it off.
It works by mimicking the hormone GLP-1 that targets areas of the brain involved in regulating appetite and food intake. This can help you eat less, which can lead to weight loss. It should be used with a nutritional plan and increased physical activity. Adults lost on average 35 lbs, or 15% of their body weight, while taking Semaglutide in a 68 week study.
Contact our team to schedule your consultation with our medical director and wellness experts. We will educate you on any contraindications and possible side effects. We will recommend nutritional guidelines and increased activity workouts.
Weeks 1-4 | 0.25mg Weeks 5-8 | 0.50mgWeeks 9-12 | 0.75mg
No, Semaglutide is not a type of insulin or a substitute for insulin. Semaglutide does stimulate your pancreas to release insulin when glucose (sugar) is present. Because Semaglutide relies upon your body’s own insulin to have this effect, Semaglutide isn’t used when your pancreas can’t make insulin, such as in patients in type 1 diabetes.
No, Semaglutide is not a stimulant. While other weight loss medications, like phentermine, have stimulating effects that help curb your appetite, Semaglutide works differently (see How Does It Work).
GLP-1 agonists like Semaglutide help to control your blood sugar, but people taking them also tend to lose weight. GLP-1, the key hormone involved, slows down how fast your stomach empties food (called gastric emptying). And in addition to causing your pancreas to release insulin, Semaglutide also blocks a hormone that causes your liver to release sugar (glucagon). Together, these functions can help you feel less hungry, causing you to eat less food and lose more weight.
Yes, it is believed that Semaglutide can help curb your appetite. In addition to slowing gastric emptying to make you feel full for longer, GLP-1 also plays a direct role in how your appetite is regulated.
With Semaglutide, you will slowly work your way up to the target dose at which time you will see the most amount of weight loss. This was the case in the clinical trials, where participants had their dose adjusted until they reached 2.4 mg once weekly. In the phase 3 trial that measured outcomes at 20 weeks, most participants were able to reach the full dose and also lost weight as their dose was increased. They saw additional weight loss over the remaining 48 weeks at the full dose. It is important to keep in mind that weight loss can take time, and you’ll see the best results when you are using your medication in combination with a healthy diet and exercise. Sometimes the medication may not work for you, or you may not be able to tolerate the full dose due to side effects. This could be related to a metabolic syndrome, in which our lipotropic injections and NAD+ injections will help and come in great benefits!
Currently, Semaglutide is only FDA-approved to help with blood sugar control in type 2 diabetes and to lower the risk of major cardiovascular events (like heart attack and stroke) in people with both type 2 diabetes and heart disease. If you are taking Semaglutide for either of these reasons, you’ll take it as directed by your healthcare provider since you are using it to manage a chronic condition. But if you do not have type 2 diabetes and are looking to try Semaglutide to help you lose weight, we’ll have a better idea of long-term safety once the FDA reviews data for this new indication. What we do know is that study participants received treatment for a period of 68 weeks (about 1.5 years) during each of the four trials conducted by the company.
Yes. Semaglutide is considered to be safe and effective when used as indicated. But safe doesn’t mean that there aren’t risks. Semaglutide also carries a boxed warning about thyroid C-cell tumors occurring in rodents (with unknown risk in humans), and Semaglutide shouldn’t be used if you or your family have a history of certain thyroid cancers. Semaglutide should not be used in people with type-1 diabetes or a history of pancreatitis. Semaglutide should be used cautiously for people on other blood sugar lowering medications.
No. Semaglutide is not covered by insurance for people who are not diabetic type 2 and wanting to just simply lose weight. If you are Diabetic Type 2, than it may be covered by your insurance with proper documentations such as Metformin failing to control your diabetic condition. You will also need a Prior Authorization with your PCP. The second option is for those who were prescribed a medication for weight loss and it failed to work, and also have documentation of Chronic Obesity and BMI>30.
Contact us at 833-424-9378.Our team will schedule your consultation and set up your appointment to start your Semaglutide injections.
Mon-Fri: 9am-5:30pmSat & Sun: 10am-4pmBy appointment or walk-in